ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      ARK Invest Biotech Active

      ARK Genomic Revolution ETF

      The ARK Genomic Revolution ETF¡¯s (¡°Fund¡±) investment objective is long-term growth of capital.

      $24.91

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      ARK Genomic Revolution ETF ARKG
      Fund Size
      $955M
      Dividend
      -
      Fees
      0.75%
      ARK Innovation ETF ARKK
      Fund Size
      $5.11B
      Dividend
      -
      Fees
      0.75%
      ARK Next Generation Internet ETF ARKW
      Fund Size
      $1.5B
      Dividend
      -
      Fees
      0.75%
      ARK Fintech Innovation ETF ARKF
      Fund Size
      $905M
      Dividend
      -
      Fees
      0.75%
      ARK Autonomous Technology & Robotics ETF ARKQ
      Fund Size
      $856M
      Dividend
      -
      Fees
      0.75%
      View 9 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $9.54B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.06 %
      Beta Indicates the relationship between the price performance of a share and the market. 1.5812
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 39.91
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -16.08
      Profitable Companies 14
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 129.88
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.86
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 5.33
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT -8.77
      Enterprise Value to Revenue Enterprise value divided by revenue 25.02
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.1
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. NaN
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -423.27%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. -33.97%
      Return on Assets Indicates a company's profitability in relation to its total assets. -20.82%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -189.63%

      Industries

      Healthcare 84.8%
      Other 6.1%
      Technology 6.1%
      N/A 3.0%

      Market cap

      Micro Cap 4%
      Small Cap 46%
      Mid Cap 36%
      Large Cap 13%
      Mega Cap 0%

      33 Investments

      P/E-Ratio
      Total Investment
      Weight
      Twist Bioscience Corp logo

      TWST - Professional, Scientific, and Technical Services

      Twist Bioscience Corp

      P/E-Ratio
      -19.0
      Total Investment
      $80.8M
      Weight
      8.5%
      Tempus AI Inc logo

      TEM

      Tempus AI Inc

      P/E-Ratio
      -6.0
      Total Investment
      $79.1M
      Weight
      8.3%
      CRISPR Therapeutics AG logo

      CRSP - Manufacturing

      CRISPR Therapeutics AG

      P/E-Ratio
      -9.6
      Total Investment
      $75.6M
      Weight
      7.9%
      Recursion Pharmaceuticals Inc logo

      RXRX - Professional, Scientific, and Technical Services

      Recursion Pharmaceuticals Inc

      P/E-Ratio
      -3.0
      Total Investment
      $65.8M
      Weight
      6.9%
      Guardant Health Inc logo

      GH - Manufacturing

      Guardant Health Inc

      P/E-Ratio
      -20.2
      Total Investment
      $61.3M
      Weight
      6.4%
      Natera Inc logo

      NTRA - Health Care and Social Assistance

      Natera Inc

      P/E-Ratio
      -90.6
      Total Investment
      $56.6M
      Weight
      5.9%
      Schrodinger Inc/United States logo

      SDGR - Manufacturing

      Schrodinger Inc/United States

      P/E-Ratio
      -7.9
      Total Investment
      $50.6M
      Weight
      5.3%
      Adaptive Biotechnologies Corp logo

      ADPT - Manufacturing

      Adaptive Biotechnologies Corp

      P/E-Ratio
      -16.5
      Total Investment
      $43.8M
      Weight
      4.6%
      Beam Therapeutics Inc logo

      BEAM - Manufacturing

      Beam Therapeutics Inc

      P/E-Ratio
      -4.2
      Total Investment
      $39.4M
      Weight
      4.1%
      CareDx Inc logo

      CDNA - Health Care and Social Assistance

      CareDx Inc

      P/E-Ratio
      14.4
      Total Investment
      $36.4M
      Weight
      3.8%
      Veracyte Inc logo

      VCYT - Health Care and Social Assistance

      Veracyte Inc

      P/E-Ratio
      90.1
      Total Investment
      $35.1M
      Weight
      3.7%
      Absci Corp logo

      ABSI - Professional, Scientific, and Technical Services

      Absci Corp

      P/E-Ratio
      -4.7
      Total Investment
      $30M
      Weight
      3.1%
      Ionis Pharmaceuticals Inc logo

      IONS - Manufacturing

      Ionis Pharmaceuticals Inc

      P/E-Ratio
      -25.3
      Total Investment
      $28.2M
      Weight
      3.0%
      10X Genomics Inc logo

      TXG - Professional, Scientific, and Technical Services

      10X Genomics Inc

      P/E-Ratio
      -20.5
      Total Investment
      $26.8M
      Weight
      2.8%
      Personalis Inc logo

      PSNL - Health Care and Social Assistance

      Personalis Inc

      P/E-Ratio
      -4.7
      Total Investment
      $25.6M
      Weight
      2.7%
      Intellia Therapeutics Inc logo

      NTLA - Manufacturing

      Intellia Therapeutics Inc

      P/E-Ratio
      -2.5
      Total Investment
      $25.5M
      Weight
      2.7%
      Arcturus Therapeutics Holdings logo

      ARCT - Manufacturing

      Arcturus Therapeutics Holdings

      P/E-Ratio
      -7.7
      Total Investment
      $23.7M
      Weight
      2.5%
      Nurix Therapeutics Inc logo

      NRIX - Manufacturing

      Nurix Therapeutics Inc

      P/E-Ratio
      -8.4
      Total Investment
      $18.2M
      Weight
      1.9%
      Amgen Inc logo

      AMGN - Manufacturing

      Amgen Inc

      P/E-Ratio
      23.4
      Total Investment
      $16.9M
      Weight
      1.8%
      Butterfly Network Inc logo

      BFLY - Healthcare

      Butterfly Network Inc

      P/E-Ratio
      -6.2
      Total Investment
      $15.1M
      Weight
      1.6%
      908 Devices Inc logo

      MASS - Manufacturing

      908 Devices Inc

      P/E-Ratio
      -12.2
      Total Investment
      $14.5M
      Weight
      1.5%
      Pacific Biosciences of Califor logo

      PACB - Manufacturing

      Pacific Biosciences of Califor

      P/E-Ratio
      -0.7
      Total Investment
      $12.6M
      Weight
      1.3%
      Vertex Pharmaceuticals Inc logo

      VRTX - Manufacturing

      Vertex Pharmaceuticals Inc

      P/E-Ratio
      27.6
      Total Investment
      $12.3M
      Weight
      1.3%
      Veeva Systems Inc logo

      VEEV - Manufacturing

      Veeva Systems Inc

      P/E-Ratio
      54.2
      Total Investment
      $11.7M
      Weight
      1.2%
      Illumina Inc logo

      ILMN - Manufacturing

      Illumina Inc

      P/E-Ratio
      12.6
      Total Investment
      $11M
      Weight
      1.2%
      HoMEÔçÒÒŮѸÀ×